Biotech NewsHalozyme (HALO) Reports $1.179B Revenue and 65% Royalty Growth BioTech Health XOctober 2, 2025 Halozyme Therapeutics Inc. (NASDAQ:HALO) is a biotechnology company headquartered in San Diego, California, that has become a recognized… 0 Shares 0 0 0 0 0 0 0